evidencegaps
Primary study · included by 1 review

Retrospective assessment of neoadjuvant camrelizumab combined with induction chemotherapy: efficacy in laryngeal preservation for advanced hypopharyngeal and laryngeal squamous cell carcinoma.

Peng 2024 · Peng Jin, Luo Guangfeng, Yu Yongchao, et al. · Cancer immunology, immunotherapy : CII · 2024

Included by

The Efficacy and Safety of Neoadjuvant Immunotherapy in Pan-Squamous Cell Carcinomas: A Meta-Analysis of Esophageal, Head and Neck, Cervical, Lung, Cutaneous, and Oral Squamous Cell Carcinomas.
Non-Cochrane · intervention · 2026 · cited as Peng 2024 · Supplementary Table S1; reference list

The review does not say which of its outcomes this study informs.

1 including review in total.